Bülent Arman Aksoy (Bulent Arman Aksoy)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Natural Killer Cells

Ejection Fraction

Top Venues

Cancer research

Nature communications

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Guillermo O Rangel Rivera, Connor J Dwyer, Hannah M Knochelmann, Aubrey S Smith, Bülent Arman Aksoy, Anna C Cole, Megan M Wyatt, Soundharya Kumaresan, Jessica E Thaxton, Gregory B Lesinski, Chrystal M Paulos
Progressively enhancing stemness of adoptively transferred T cells with PI3Kδ blockade improves metabolism and anti-tumor immunity. Cancer research (2023)
Emilio Sanseviero, Erin M O'Brien, Jenna R Karras, Tamer Basel Shabaneh, Bülent Arman Aksoy, Wei Xu, Cathy Zheng, Xiangfan Yin, Xiaowei Xu, Giorgos C Karakousis, Ravi K Amaravadi, Brian Nam, Mary Jo Turk, Jeff Hammerbacher, Mark P Rubinstein, Lynn M Schuchter, Tara C Mitchell, Jingjing Liu, Erica L Stone
Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control. Cancer immunology research 7 (8) (2019)
Jeffrey Vedanayagam, Walid K Chatila, Bülent Arman Aksoy, Sonali Majumdar, Anders Jacobsen Skanderup, Emek Demir, Nikolaus Schultz, Chris Sander, Eric C Lai
Cancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesis. Nature communications 10 (1) (2019)
Alexandra Snyder, Tavi Nathanson, Samuel A Funt, Arun Ahuja, Jacqueline Buros, Matthew D Hellmann, Eliza Chang, Bülent Arman Aksoy, Hikmat Al-Ahmadie, Erik Yusko, Marissa Vignali, Sharon Benzeno, Mariel Boyd, Meredith Moran, Gopa Iyer, Harlan S Robins, Elaine R Mardis, Taha Merghoub, Jeff Hammerbacher, Jonathan E Rosenberg, Dean F Bajorin
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis. PLoS medicine 14 (5) (2017)